Jazz Pharmaceuticals (JAZZ) PT Lowered to $135 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst David Risinger lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $135.00 (from $168.00) for 3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
